David S Kim1, Sarah Rowland-Jones2, Ester Gea-Mallorquí2. 1. Medical Sciences Division, University of Oxford, Oxford, United Kingdom. 2. Viral Immunology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Abstract
In December 2019, an outbreak of a novel coronavirus (SARS-CoV-2) in Wuhan, China resulted in the current COVID-19 global pandemic. The human immune system has not previously encountered this virus, raising the important question as to whether or not protective immunity is generated by infection. Growing evidence suggests that protective immunity can indeed be acquired post-infection-although a handful of reinfection cases have been reported. However, it is still unknown whether the immune response to SARS-CoV-2 leads to some degree of long-lasting protection against the disease or the infection. This review draws insights from previous knowledge regarding the nature and longevity of immunity to the related virus, SARS-CoV, to fill the gaps in our understanding of the immune response to SARS-CoV-2. Deciphering the immunological characteristics that give rise to protective immunity against SARS-CoV-2 is critical to guiding vaccine development and also predicting the course of the pandemic. Here we discuss the recent evidence that characterises the adaptive immune response against SARS-CoV-2 and its potential implications for the generation of memory responses and long-term protection.
In December 2019, an outbreak of a novel coronavirus (n class="Species">SARS-CoV-2) in Wuhan, China resulted in the current COVID-19 global pandemic. The human immune system has not previously encountered this virus, raising the important question as to whether or not protective immunity is generated by infection. Growing evidence suggests that protective immunity can indeed be acquired post-infection-although a handful of reinfection cases have been reported. However, it is still unknown whether the immune response to SARS-CoV-2 leads to some degree of long-lasting protection against the disease or the infection. This review draws insights from previous knowledge regarding the nature and longevity of immunity to the related virus, SARS-CoV, to fill the gaps in our understanding of the immune response to SARS-CoV-2. Deciphering the immunological characteristics that give rise to protective immunity against SARS-CoV-2 is critical to guiding vaccine development and also predicting the course of the pandemic. Here we discuss the recent evidence that characterises the adaptive immune response against SARS-CoV-2 and its potential implications for the generation of memory responses and long-term protection.
Authors: M S Yip; H L Leung; P H Li; C Y Cheung; I Dutry; D Li; M Daëron; R Bruzzone; J Sm Peiris; M Jaume Journal: Hong Kong Med J Date: 2016-06 Impact factor: 2.227
Authors: F Javier Ibarrondo; Jennifer A Fulcher; David Goodman-Meza; Julie Elliott; Christian Hofmann; Mary A Hausner; Kathie G Ferbas; Nicole H Tobin; Grace M Aldrovandi; Otto O Yang Journal: N Engl J Med Date: 2020-07-21 Impact factor: 91.245
Authors: Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan Journal: Science Date: 2020-02-19 Impact factor: 47.728
Authors: Jessica J Manson; Colin Crooks; Meena Naja; Amanda Ledlie; Bethan Goulden; Trevor Liddle; Emon Khan; Puja Mehta; Lucia Martin-Gutierrez; Kirsty E Waddington; George A Robinson; Liliana Ribeiro Santos; Eve McLoughlin; Antonia Snell; Christopher Adeney; Ina Schim van der Loeff; Kenneth F Baker; Christopher J A Duncan; Aidan T Hanrath; B Clare Lendrem; Anthony De Soyza; Junjie Peng; Hajar J'Bari; Mandy Greenwood; Ellie Hawkins; Hannah Peckham; Michael Marks; Tommy Rampling; Akish Luintel; Bryan Williams; Michael Brown; Mervyn Singer; Joe West; Elizabeth C Jury; Matthew Collin; Rachel S Tattersall Journal: Lancet Rheumatol Date: 2020-08-21
Authors: Julie E Martin; Mark K Louder; LaSonji A Holman; Ingelise J Gordon; Mary E Enama; Brenda D Larkin; Charla A Andrews; Leatrice Vogel; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; Martha Nason; John R Mascola; Gary J Nabel; Barney S Graham Journal: Vaccine Date: 2008-09-26 Impact factor: 3.641
Authors: Danielle Thompson; Ben Guenther; Darly Manayani; Jason Mendy; Jonathan Smith; Diego A Espinosa; Eva Harris; Jeff Alexander; Lo Vang; Christopher S Morello Journal: PLoS Negl Trop Dis Date: 2022-07-06
Authors: Paula Piñero; Francisco M Marco De La Calle; Lydia Horndler; Balbino Alarcón; Marisol Uribe Barrientos; Héctor Sarmiento; Fabián Tarín Journal: Sci Rep Date: 2021-05-21 Impact factor: 4.379
Authors: Aljawharah Alrubayyi; Ester Gea-Mallorquí; Emma Touizer; Dan Hameiri-Bowen; Jakub Kopycinski; Bethany Charlton; Natasha Fisher-Pearson; Luke Muir; Annachiara Rosa; Chloe Roustan; Christopher Earl; Peter Cherepanov; Pierre Pellegrino; Laura Waters; Fiona Burns; Sabine Kinloch; Tao Dong; Lucy Dorrell; Sarah Rowland-Jones; Laura E McCoy; Dimitra Peppa Journal: Res Sq Date: 2021-03-17
Authors: Aljawharah Alrubayyi; Ester Gea-Mallorquí; Emma Touizer; Dan Hameiri-Bowen; Jakub Kopycinski; Bethany Charlton; Natasha Fisher-Pearson; Luke Muir; Annachiara Rosa; Chloe Roustan; Christopher Earl; Peter Cherepanov; Pierre Pellegrino; Laura Waters; Fiona Burns; Sabine Kinloch; Tao Dong; Lucy Dorrell; Sarah Rowland-Jones; Laura E McCoy; Dimitra Peppa Journal: bioRxiv Date: 2021-02-16